Vaxcyte (PCVX) Change in Cash (2019 - 2026)
Vaxcyte (PCVX) posted quarterly Change in Cash of $86.9 million for Q1 2026, up 311.78% year-over-year from $21.1 million in Q1 2025, and up 181.11% quarter-over-quarter from -$107.1 million in Q4 2025.
Vaxcyte (PCVX) Change in Cash (2019 - 2026) Analysis & Trends
Vaxcyte (PCVX) has reported Change in Cash for 8 consecutive years, with $86.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Cash rose 311.78% year-over-year to $86.9 million; the TTM figure through Mar 2026 stood at -$85.9 million (up 67.53% YoY), while the FY2025 annual figure was -$213.8 million, down 2184.11% from the prior year.
- Change in Cash improved to $86.9 million in Q1 2026 per PCVX's latest filing, from -$107.1 million in the prior quarter.
- Across five years, Change in Cash topped out at $556.3 million in Q4 2022 and bottomed at -$662.3 million in Q4 2024.
- Historically, Change in Cash has averaged $11.3 million across 5 years, with a median of $14.3 million in 2023.
- Annual changes were most pronounced in 2023 — Change in Cash tumbled 442.14% — and 2024, when it jumped 3609.86%.
- Vaxcyte's Change in Cash stood at $556.3 million in 2022, then plunged by 126.55% to -$147.7 million in 2023, then tumbled by 348.47% to -$662.3 million in 2024, then surged by 83.83% to -$107.1 million in 2025, then soared by 181.11% to $86.9 million in 2026.
- Business Quant data shows PCVX's Change in Cash at $86.9 million in Q1 2026, -$107.1 million in Q4 2025, and -$25.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Vaxcyte | 8.41 Bn | 8.41 Bn | - | -77.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -77.65 Mn |
| Mar 31, 2026 | 86.88 Mn |
| Dec 31, 2025 | -107.12 Mn |
| Sep 30, 2025 | -25.52 Mn |
| Jun 30, 2025 | -40.11 Mn |
| Mar 31, 2025 | -41.03 Mn |
| Dec 31, 2024 | -662.31 Mn |
| Sep 30, 2024 | 531.73 Mn |
| Jun 30, 2024 | -92.84 Mn |
| Mar 31, 2024 | 214.06 Mn |
| Dec 31, 2023 | -147.68 Mn |
| Sep 30, 2023 | 14.33 Mn |
| Jun 30, 2023 | 150.58 Mn |
| Mar 31, 2023 | -454.21 Mn |
| Dec 31, 2022 | 556.26 Mn |
| Sep 30, 2022 | 40.23 Mn |
| Jun 30, 2022 | 36.43 Mn |
| Mar 31, 2022 | 132.76 Mn |
| Dec 31, 2021 | -43.06 Mn |
| Sep 30, 2021 | -38.95 Mn |